top of page
RESTORING THE POWER OF ANTIBIOTICS
Restoring
the power
of antibiotics
We're on a mission to restore the efficacy of antibiotics against drug-resistant infections
That's why we're developing PBT2.
A small molecule oral therapeutic for treatment of community-acquired bacterial pneumonia (CABP). ​
​
PBT2 is safe, low cost to manufacture, orally bioavailable and has shown no development of resistance.
bottom of page